Published in Women's Health Weekly, November 29th, 2001
NuvaRing is a flexible, transparent ring that provides month-long contraceptive protection and can be discretely administered by a woman in the privacy of her own home. The product works by releasing a continuous low dose of estrogen and progestin, on average 0.120 mg of etonogestrel and 0.015 mg of ethinyl estradiol, per day over a 21-day period of use.
"NuvaRing truly is birth control for the new millennium," said Dr. Larry Seidman, clinical...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.